TIMP1 and Hepatic fibrosis: Statins can also downregulate profibrogenic gene expressions (TGF-β1, α-SMA, and tissue inhibitor of metalloproteinases-1) and protein expression of αSMA in HSCs; thus, it reduces liver fibrosis [53].